| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1035070713 |
| P356 | DOI | 10.1007/S10549-008-0044-Z |
| P8608 | Fatcat ID | release_fxej2kgr5falleqb4irjvzxeqm |
| P932 | PMC publication ID | 4066453 |
| P698 | PubMed publication ID | 18481172 |
| P2093 | author name string | Gokul M Das | |
| Wensheng Liu | |||
| Matthew B Podgorsak | |||
| Margot M Ip | |||
| P2860 | cites work | NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription | Q24600573 |
| p53 and breast cancer, an update | Q28242379 | ||
| DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2 | Q28254119 | ||
| Amplification of a gene encoding a p53-associated protein in human sarcomas | Q28270924 | ||
| Targeting survivin in cancer therapy: fulfilled promises and open questions | Q28291799 | ||
| Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials | Q29031162 | ||
| p53 in health and disease | Q29619939 | ||
| Effector genes altered in MCF-7 human breast cancer cells after exposure to fractionated ionizing radiation | Q30984038 | ||
| Induction of p21CIP/WAF-1 and G2 arrest by ionizing irradiation impedes caspase-3-mediated apoptosis in human carcinoma cells | Q33228616 | ||
| Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis | Q33861700 | ||
| The MDM2 gene amplification database | Q34672224 | ||
| The role of p53 in determining sensitivity to radiotherapy | Q35058584 | ||
| Analysis of p53-regulated gene expression patterns using oligonucleotide arrays | Q35191756 | ||
| Interactions between radiation and endocrine therapy in breast cancer | Q35540780 | ||
| The p53 protein family and radiation sensitivity: Yes or no? | Q35805241 | ||
| Gene expression profiling after irradiation: clues to understanding acute and persistent responses? | Q35805245 | ||
| Molecular circuits of apoptosis regulation and cell division control: the survivin paradigm | Q35813973 | ||
| Steroid receptors in human breast cancer | Q35879372 | ||
| Estrogen-receptor biology: continuing progress and therapeutic implications | Q36065443 | ||
| The use of radiotherapy after mastectomy: a review of the literature | Q36065486 | ||
| Use of conventional radiation therapy as part of breast-conserving treatment | Q36065489 | ||
| Accelerated partial breast irradiation as a part of breast conservation therapy | Q36065493 | ||
| Tumor suppressor genes in breast cancer: the gatekeepers and the caretakers | Q36391987 | ||
| Survivin study: an update of "what is the next wave"? | Q36430244 | ||
| p53 as a target for anti-cancer drug development. | Q36475676 | ||
| Importance of p53 for cancer onset and therapy | Q36574368 | ||
| Restoration of wild-type p53 function in human cancer: relevance for tumor therapy. | Q36710840 | ||
| Wild-type p53: tumors can't stand it. | Q36756803 | ||
| TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes | Q36777326 | ||
| Radiosensitization by antisense anti-MDM2 mixed-backbone oligonucleotide in in vitro and in vivo human cancer models | Q38344527 | ||
| Microarray analysis of p53 target gene expression patterns in the spleen and thymus in response to ionizing radiation. | Q38350029 | ||
| Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis | Q40093792 | ||
| Down-regulation of inhibitor of apoptosis proteins by deguelin selectively induces apoptosis in breast cancer cells | Q40221077 | ||
| Down-regulation of survivin by ultraviolet C radiation is dependent on p53 and results in G(2)-M arrest in A549 cells | Q40234556 | ||
| Regulation of survivin by retinoic acid and its role in paclitaxel-mediated cytotoxicity in MCF-7 breast cancer cells | Q40306577 | ||
| Estrogen receptor-alpha binds p53 tumor suppressor protein directly and represses its function | Q40318351 | ||
| p53-dependent apoptosis or growth arrest induced by different forms of radiation in U2OS cells: p21WAF1/CIP1 repression in UV induced apoptosis | Q40926717 | ||
| The fate of irradiated tumor cells | Q46772707 | ||
| Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. | Q47252460 | ||
| mdm2 gene alterations and mdm2 protein expression in breast carcinomas | Q60609646 | ||
| Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas | Q72769128 | ||
| Inhibition of signal transducer and activator of transcription 3 activity results in down-regulation of Survivin following irradiation | Q79377407 | ||
| p21 blocks irradiation-induced apoptosis downstream of mitochondria by inhibition of cyclin-dependent kinase-mediated caspase-9 activation | Q79405060 | ||
| Radiation therapy for invasive breast cancer: not just for local control | Q81498277 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adaptive radiation therapy | Q180507 |
| P304 | page(s) | 43-50 | |
| P577 | publication date | 2008-05-15 | |
| P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
| P1476 | title | Disruption of estrogen receptor alpha-p53 interaction in breast tumors: a novel mechanism underlying the anti-tumor effect of radiation therapy | |
| P478 | volume | 115 |
| Q40143097 | AGR2 oncoprotein inhibits p38 MAPK and p53 activation through a DUSP10-mediated regulatory pathway |
| Q24322033 | Activation of p53 transcriptional activity by SMRT: a histone deacetylase 3-independent function of a transcriptional corepressor |
| Q92878886 | Analysis of the TP53 Deleterious Single Nucleotide Polymorphisms Impact on Estrogen Receptor Alpha-p53 Interaction: A Machine Learning Approach |
| Q55421291 | ERβ alters the chemosensitivity of luminal breast cancer cells by regulating p53 function. |
| Q37046414 | ERβ decreases the invasiveness of triple-negative breast cancer cells by regulating mutant p53 oncogenic function |
| Q37085951 | Estrogen receptor alpha (ERα/ESR1) mediates the p53-independent overexpression of MDM4/MDMX and MDM2 in human breast cancer |
| Q39506267 | Functional significance of Aurora kinase A regulatory interactions with p53-ERα complex in human breast cancer cells |
| Q55515610 | Good Guy or Bad Guy? The Duality of Wild-Type p53 in Hormone-Dependent Breast Cancer Origin, Treatment, and Recurrence. |
| Q34133268 | Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells |
| Q36906240 | Interaction between p53 and estradiol pathways in transcriptional responses to chemotherapeutics |
| Q34093947 | Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation. |
| Q36719519 | Molecular analysis and anticancer properties of two identified isolates, Fusarium solani and Emericella nidulans isolated from Wady El-Natron soil in Egypt against Caco-2 (ATCC) cell line |
| Q35685892 | Mouse models of estrogen receptor-positive breast cancer |
| Q64924815 | Potential interference of aluminum chlorohydrate with estrogen receptor signaling in breast cancer cells. |
| Q37295467 | Survivin regulation by HER2 through NF-κB and c-myc in irradiated breast cancer cells |
| Q93123334 | TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast Cancer |
| Q36149280 | The DNA binding and accumulation of p53 from breast cancer cell lines and the link with serine 15 phosphorylation |
| Q27027865 | The p53-estrogen receptor loop in cancer |
| Q33632616 | Tumor suppressor p53 and estrogen receptors in nuclear-mitochondrial communication |
| Q35889599 | miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells. |
Search more.